Skip header and navigation

3 records – page 1 of 1.

Medical services of a multicultural summer camp event: experiences from the 22nd World Scout Jamboree, Sweden 2011.

https://arctichealth.org/en/permalink/ahliterature113730
Source
BMC Health Serv Res. 2013;13:187
Publication Type
Article
Date
2013
Author
Ib Jammer
Christina Allansdotter Andersson
Anna Lindholm Olinder
Bo Selander
Anna Elmerfeldt Wallinder
Stefan Rocco Hansson
Source
BMC Health Serv Res. 2013;13:187
Date
2013
Language
English
Publication Type
Article
Keywords
Adolescent
Adolescent Health Services - organization & administration
Camping
Delivery of Health Care - organization & administration
Health planning
Health services needs and demand
Humans
Male
Sweden
Abstract
Prevention and treatment of medical issues are the main task of a health service at a youth camp. However, only few reports about organisation and implementation of camp health care are available. This makes it difficult for future camp directors to plan and estimate the health care needed for a certain camp size. We summarize the experience in planning and running health care for the 22nd World Scout Jamboree (WSJ) 2011 in Sweden.
During the WSJ, 40,061 participants from 146 nations were gathered in southern Sweden to a 12 day summer camp. Another 31,645 people were visitors. Members for the medical service were 153 volunteering medical professionals with different language and cultural backgrounds from 18 different countries.
Of 40,061 participants 2,893 (7.3%) needed medical assistance. We found an equal distribution of cases to approximately one third surgical, one third medical and one third unspecified cases. Much energy was spent on health prevention, hygiene measures and organizing of psychological support.
A youth camp with a multicultural population and a size of a small city demands flexible staff with high communication skills. Special attention should be paid in prevention of contagious diseases and taking care of psychological issues.
Notes
Cites: Emerg Infect Dis. 2010 Feb;16(2):189-9620113546
Cites: Inj Prev. 2009 Dec;15(6):413-719959735
Cites: J Sch Health. 2010 Dec;80(12):588-9821087255
Cites: Mil Med. 2010 Dec;175(12):990-421265307
Cites: Pediatrics. 2011 Apr;127(4):794-921444589
Cites: New Dir Youth Dev. 2011 Summer;2011(130):73-8721786411
Cites: N Engl J Med. 2011 Nov 10;365(19):1771-8021696328
Cites: Lancet. 2012 Jan 14;379(9811):153-6421855993
Cites: Epidemiol Infect. 2003 Dec;131(3):1063-914959771
Cites: Epidemiol Infect. 2004 Apr;132(2):223-915061496
Cites: Offentl Gesundheitswes. 1989 Oct;51(10):629-342531316
Cites: Wis Med J. 1996 Aug;95(8):565-98772417
Cites: Pediatrics. 2005 Jun;115(6):1770-315930244
Cites: Child Adolesc Psychiatr Clin N Am. 2007 Oct;16(4):769-88, vi17823055
Cites: Br Dent J. 2008 Jan 12;204(1):33-618192997
Cites: J Burn Care Res. 2010 Sep-Oct;31(5):740-920644489
PubMed ID
23692881 View in PubMed
Less detail

N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.

https://arctichealth.org/en/permalink/ahliterature58331
Source
J Pediatr. 2003 Dec;143(6):713-9
Publication Type
Article
Date
Dec-2003
Author
Terhi Ahola
Risto Lapatto
Kari O Raivio
Bo Selander
Lennart Stigson
Baldvin Jonsson
Finn Jonsbo
Gitte Esberg
Sören Stövring
Sveinn Kjartansson
Tom Stiris
Kristin Lossius
Kristina Virkola
Vineta Fellman
Author Affiliation
Hospital for Children and Adolescents, Helsinki University Central Hospital, Helsinki, Finland.
Source
J Pediatr. 2003 Dec;143(6):713-9
Date
Dec-2003
Language
English
Publication Type
Article
Keywords
Antioxidants - administration & dosage
Bronchopulmonary Dysplasia - prevention & control
Cystine - administration & dosage - analogs & derivatives
Double-Blind Method
Female
Humans
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Infusions, Intravenous
Male
Research Support, Non-U.S. Gov't
Abstract
OBJECTIVE: To evaluate whether N-acetylcysteine (NAC) infusion during the first week of life reduces the risk of death or bronchopulmonary dysplasia (BPD) in infants with extremely low birth weight.Study design In a Nordic multicenter, double-blind trial, infants (n=391) weighing 500 to 999 g and on ventilator or nasal continuous positive airway pressure were randomized before the age of 36 hours to receive NAC 16 to 32 mg/kg/d (n=194) or placebo (n=197) intravenously for 6 days. Primary end points were death or BPD, defined as supplementary oxygen requirement at 36 weeks' gestational age. RESULTS: There was no difference in the combined incidence of the primary end points death or BPD, 51% vs. 49%, between the NAC group and control group. Also similar was the incidence of BPD in survivors at 36 weeks' gestational age, 40% vs. 40%, and the mean oxygen requirement at the age of 28 days, 31.2% vs. 30.7%, respectively. The severity of BPD was similar in both groups. CONCLUSIONS: A 6-day course of intravenous N-acetylcysteine at the dosage used does not prevent BPD or death in infants with extremely low birth weight.
Notes
Comment In: J Pediatr. 2003 Dec;143(6):697-814657807
PubMed ID
14657813 View in PubMed
Less detail

[Swedish guidelines for prevention and treatment of pain in the newborn infant]

https://arctichealth.org/en/permalink/ahliterature58511
Source
Lakartidningen. 2002 Apr 25;99(17):1946-9
Publication Type
Article
Date
Apr-25-2002
Author
Björn A Larsson
Maria Gradin
Viveka Lind
Bo Selander
Author Affiliation
Astrid Lindgrens Barnsjukhus, Stockholm. bjorn.larsson@ks.se
Source
Lakartidningen. 2002 Apr 25;99(17):1946-9
Date
Apr-25-2002
Language
Swedish
Publication Type
Article
Keywords
English Abstract
Humans
Infant, Newborn
Pain - prevention & control - psychology - therapy
Sweden
Abstract
A Swedish national consensus statement concerning prevention and management of pain in the newborn infant has been prepared by members of the Swedish Paediatric Pain Society (Svensk Barnsmärtförening, SBSF). The document is based on the Consensus Statement for the Prevention and Management of Pain in the Newborn Infant by Anand et al [1].
PubMed ID
12043418 View in PubMed
Less detail